Tag: Vaccines
FDA Tells Vaccine Makers to Update Boosters to Target Omicron Subvariants
Pfizer and Moderna are expected to start producing reformulated doses this summer
U.S. Orders 105 Million More Pfizer Shots for Fall Booster Campaign
Both Pfizer and Moderna have reported positive results with updated vaccines that target the omicron variant
Two Doses of BNT162b2 Moderately Effective for 5- to 11-Year-Olds
Moderate effectiveness against documented infection and symptomatic COVID-19 for those vaccinated on or after Nov. 23, 2021
ACIP Recommends COVID-19 Vaccines for Children Aged ≥6 Months
ACIP interim recommendations presented for Moderna, Pfizer-BioNTech mRNA vaccines for children aged 6 months to 5 years
U.S. Begins Targeted Vaccine Rollout Against Monkeypox
HHS is rapidly expanding access to hundreds of thousands of doses of the Jynneos vaccine
FDA Panel Supports Rollout of Tweaked Booster Shots From Moderna, Pfizer This Fall
Advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations
Vaccines Estimated to Have Prevented 19.8 Million COVID-19 Deaths
More deaths would have been averted had vaccine coverage targets from COVAX and WHO been met
Fourth Dose of BNT162b2 Prevents Severe COVID-19 in Nursing Home Residents
Substantial protection against hospitalizations, deaths seen among long-term care facility residents during omicron surge
Pfizer Has Two Updated Booster Shots to Help Fight Omicron
Company said Saturday that it was confident its new booster candidates are better than their predecessor
FDA Panel to Weigh Improved Booster Shots From Moderna, Pfizer
Both Pfizer and Moderna have been testing updated booster shots that target the omicron variant
